Having trouble accessing articles? Reset your cache.

Medical Research Council pharmaceuticals news

The U.K.'s three-year, £180 million ($285.8 million) Biomedical Catalyst fund awarded £39 million ($62.4 million) across 10 universities and 22 small and medium sized enterprises (SMEs) for early stage life science research. Companies receiving funding include dermatology and inflammation company Creabilis S.A. (Luxembourg, Luxembourg);

Read the full 443 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers